The stock had been a under-performer so far this month and quarter when compared to the BSE Sensex returns.
The stock hit a low of Rs 252.65 in early morning trades on the BSE
Sun Pharma, Cipla, Natco, Dr Reddy's, Torrent Pharma, Aurobindo Pharma and Strides have launched a generic version of Molnupiravir in India post approval for emergency use authorisation from DCGI
With the last two-day rally, the stock now trades at a whopping 72 per cent premium over its issue price of Rs 1,033 per share.
The management had said the company is witnessing a robust demand environment resulting in strong order inflow and pipeline
Till 10:21 am; a combined 4.9 million equity shares had changed hands and there were pending buy orders for 4.74 million shares on the NSE and BSE
RBL Bank on Saturday said its Managing Director and Chief Executive Officer Vishwavir Ahuja has proceeded on leave with immediate effect
In the past one week, the stock rallied 12 per cent when compared with a 2.8 per cent rise in the S&P BSE Sensex
The stock was trading at its highest level since December 2010.
The company's board has also approved a proposal to raise up to Rs 301 crore for the expansion of its future technologies brand Battrixx
At 10:01 am, the stock was locked at the 5 per cent upper circuit at Rs 334.95 on the BSE
Data Patterns shares were listed at Rs 864, a 48 per cent premium over its issue price of Rs 585 per share on the BSE.
Till 09:26 am; around 8.15 million equity shares or 0.30 per cent stake of the company had changed hands on the NSE, the exchange data showed
Data Patterns is likely to witness a bumper listing, with Grey Market Premium (GMP) indicating a likely 45-50 per cent premium to its issue price.
In the past two weeks, the stock price of Jyoti Resins & Adhesives had zoomed 56 per cent, as compared to 2.5 per cent decline in the S&P BSE Sensex
In the past six trading days, Infosys has gained 7 per cent after Accenture reported strong results for the quarter ended November (Q1FY22) and also gave a strong FY22 outlook
The stock listed at Rs 1,040, a 31 per cent premium to its issue price of Rs 796 per share on the National Stock Exchange.
The board of directors are scheduled to meet on Monday December 27, 2021 to consider and approve a proposal for buy-back of equity shares of the company.
The stock was up 10% in intraday trades today, but still traded below its issue price of Rs 425 per share
The stock listed at Rs 436 on the BSE and Rs 437 on the NSE, a 13 per cent below its issue price of Rs 500 per share.